These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1091605)

  • 21. [Treatment of Parkinson's syndrome using a new preparation from the series of tricyclic psychotropic drugs].
    Deze J; Völler GW
    Med Welt; 1975 Aug; 26(33-34):1457-62. PubMed ID: 1100988
    [No Abstract]   [Full Text] [Related]  

  • 22. [Therapy of Parkinsonian syndrome using L-dopa. Current state and problems].
    Fischer PA
    Nervenarzt; 1974 Dec; 45(12):617-27. PubMed ID: 4614096
    [No Abstract]   [Full Text] [Related]  

  • 23. [Modern antiparkinsonics (L-dopa and amantadine) and presentday psychiatry (author's transl)].
    Dolezalová B; Vacek J
    Cesk Psychiatr; 1976 Dec; 72(6):403-7. PubMed ID: 1000706
    [No Abstract]   [Full Text] [Related]  

  • 24. [The therapeutic effectiveness of amantadine (midantan) in parkinsonism syndromes].
    Kiseleva AM; Zlydnikov DM; Mazhinskaia VP; Lebedeva VK; Zakharova NG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):530-4. PubMed ID: 4705408
    [No Abstract]   [Full Text] [Related]  

  • 25. [Edemas and myocloni concerning a patient with Parkinson's disease treated by amantadine (author's transl)].
    Chevalier JF; Renier E; Brion S
    Encephale; 1980; 6(4):381-4. PubMed ID: 7439114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Drug therapy of parkinsonism].
    Teräväinen H; Larsen TA
    Duodecim; 1982; 98(11):892-900. PubMed ID: 6125373
    [No Abstract]   [Full Text] [Related]  

  • 27. [Current medical treatment of Parkinsonian syndromes].
    Cincă I; Bulandra R; Serbănesco A; Ninosu N
    Rev Roum Neurol; 1973; 10(4):257-85. PubMed ID: 4767886
    [No Abstract]   [Full Text] [Related]  

  • 28. [Diagnosis and therapy for patients with vascular parkinsonism].
    Takahashi H; Shinohara Y
    Nihon Naika Gakkai Zasshi; 2003 Aug; 92(8):1472-8. PubMed ID: 13677897
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacotherapy: problems and practices.
    Muenter MD
    Clin Neuropharmacol; 1986; 9 Suppl 1():S23-36. PubMed ID: 3708606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent progress in the treatment of Parkinson's disease.
    Siemers E
    Compr Ther; 1992 Sep; 18(9):20-4. PubMed ID: 1358500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Anesthesia and recovery in the patient treated by L-dopa].
    Dixneuf B
    Anesth Analg (Paris); 1975; 32(5):667-83. PubMed ID: 1221886
    [No Abstract]   [Full Text] [Related]  

  • 32. [Experience with a l-dopa retard preparation in the peroral long-term therapy of the Parkinsonian syndrome].
    Binder H; Gerstenbrand F; Grünberger J; Gründig E; Schubert H
    Nervenarzt; 1976 Nov; 47(11):656-60. PubMed ID: 826840
    [No Abstract]   [Full Text] [Related]  

  • 33. [L-dopa-induced movement disorders in Parkinson disease. Amantadine improves dyskinesia].
    MMW Fortschr Med; 2001 May; 143 Suppl 2():93. PubMed ID: 11434272
    [No Abstract]   [Full Text] [Related]  

  • 34. Amantadine reduces levodopa-induced dyskinesias in parkinsonian monkeys.
    Blanchet PJ; Konitsiotis S; Chase TN
    Mov Disord; 1998 Sep; 13(5):798-802. PubMed ID: 9756148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Long-term therapy of the Parkinson syndrome].
    Ludin HP
    Schweiz Med Wochenschr; 1984 Aug; 114(33):1131-6. PubMed ID: 6484543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Combination therapy of Parkinson's syndrome using L-dopa and a decarboxylase inhibitor].
    Fischer PA; Schneider E; Jacobi P; Maxion H
    Med Welt; 1973 Nov; 24(45):1742-6. PubMed ID: 4768206
    [No Abstract]   [Full Text] [Related]  

  • 37. [Revision of the treatment strategy in Parkinson disease].
    Staal-Schreinemachers AL; Wesseling H; Lakke JP
    Ned Tijdschr Geneeskd; 1986 May; 130(20):914-8. PubMed ID: 3724865
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effectiveness of a combination therapy in the Parkinson syndrome by amantadine hydrochloride and anticholinergic agents].
    Gospavić J; Vidaković Z
    Srp Arh Celok Lek; 1974 Jun; 102(6):447-57. PubMed ID: 4450143
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of Parkinsonian syndrome using amantadine hydrochloride].
    Schubert U; Fischer GJ; Glass J
    Z Arztl Fortbild (Jena); 1975 May; 69(9):469-76. PubMed ID: 1106004
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacological approaches to Parkinson's disease in the different phases of evolution.
    Giovannini P; Piccolo I; Scigliano G; Caraceni T
    J Neural Transm Suppl; 1986; 22():173-87. PubMed ID: 3097255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.